The Lancet Haematology
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
15-Jun-2023
THE LANCET HAEMATOLOGY: Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021
A Lancet study—the first to estimate the full global mortality burden
of Sickle Cell Disease (SCD)—has revealed a strikingly high contribution
of SCD to all-cause mortality that is not apparent when each death is
assigned to only a single cause. Credit: The Lancet
Article Information
Journal
The Lancet Haematology
Article Publication Date
2023-06-15
Article Title
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
Contact Information
How to Cite This Article
APA:
The Lancet. (2023, June 15). THE LANCET HAEMATOLOGY: Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021. Brightsurf News. https://www.brightsurf.com/news/86ZRMW68/the-lancet-haematology-global-regional-and-national-prevalence-and-mortality-burden-of-sickle-cell-disease-20002021.html
MLA:
"THE LANCET HAEMATOLOGY: Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021." Brightsurf News, Jun. 15 2023, https://www.brightsurf.com/news/86ZRMW68/the-lancet-haematology-global-regional-and-national-prevalence-and-mortality-burden-of-sickle-cell-disease-20002021.html.